Echelon Health, a global leader in preventative healthcare, has launched a groundbreaking new service that offers clients the most complete insight into their overall wellbeing to date. By combining its signature Platinum Assessment with a newly introduced Dementia Assessment, the Harley Street-based clinic is setting a new benchmark for personalised, proactive healthcare.
The Platinum Assessment is already regarded as one of the most advanced full-body health screenings available, designed to detect up to 92% of preventable causes of death in men and 95% in women. It includes a wide range of high-resolution diagnostic tests—from CT, MRI and ultrasound scans to full-body mole mapping, ECGs, and comprehensive blood analysis. Every aspect is designed to catch serious diseases such as cancer, heart disease, and aneurysms at the earliest possible stage, when treatment is most effective.
Now, the integration of a dedicated Dementia Assessment expands this offering to include the early identification of neurodegenerative conditions—at a time when global rates of dementia are rapidly increasing. The new assessment begins with an extensive panel of blood tests to screen for underlying risk factors such as diabetes, high cholesterol, and vitamin deficiencies. This is followed by a state-of-the-art 3T MRI brain scan, interpreted by a specialist neuroradiologist to detect signs of structural brain changes that may indicate early-stage dementia.
Clients also undergo the Addenbrooke’s Cognitive Examination (ACE-III), a neurocognitive test that delivers up to 97% accuracy in identifying early symptoms of cognitive decline. For those requiring additional evaluation, Echelon Health can arrange CT-PET brain imaging, which allows for the identification of amyloid plaques—one of the key indicators of Alzheimer’s disease—enabling earlier access to emerging disease-modifying therapies.
Both assessments are designed with the individual in mind, offering not only a detailed medical analysis but also a personalised health strategy based on each client’s results. All consultations and assessments are led by experts in the field, including Dr Paul Jenkins, a Cambridge-trained medical expert and Echelon’s founder, and Dr. Aijaz Khan, a highly respected Consultant Neurologist with over 25 years’ experience in cognitive decline.
The new Dementia Assessment is priced at £3,000, with 0% finance options available to make early cognitive screening more accessible. The Platinum Assessment, priced at £14,000, continues to stand as one of the most comprehensive preventative health packages available anywhere in the world.
With this new combined service, Echelon Health is reinforcing its commitment to proactive, precision-led healthcare, giving clients the tools they need to take control of both their current health and their future wellbeing.
To find out more about Echelon Health, visit the links below:
Echelon Health
68 Harley Street
London
W1G 7HE
Web: echelon.health
Tel: +44 (0)20 7580 7688
Email: info@echelon.health
Instagram: @echelon.health
Facebook: @echelonhealthltd